Australia’s New South Wales State To Fund Pilot Ribonucleic Acid (RNA) Facility
SYDNEY, Oct 21 (NNN-AGENCIES) – Australia’s New South Wales (NSW) is set to become home to Australia’s first mRNA and RNA-based development and manufacturing facility. The 96-million-Australian dollar (72-million-U.S. dollar) facility would include laboratories and pre-clinical trial spaces, that will enable early-stage RNA-based drug development. During the announcement made today,…
